Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
Titel:
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trial
Auteur:
Fleischmann, Roy Friedman, Alan Drescher, Edit Singhal, Atul Cortes-Maisonet, Gregorio Doan, Thao Lu, Wenjing Wang, Zailong Nader, Ahmed Housley, William Cohen, Stanley Taylor, Peter C Blanco, Ricardo